The true test of performance for a SPECT/CT system goes beyond its lesion detection ability. It's in dose reduction, streamlined exams, robust CT solutions and quantitative applications. And most of all, it’s the flexibility to access clinical information and demonstrating the value of nuclear medicine to your referring physicians from anywhere at anytime.
Discovery 670 DR’s Elite NXT NM detectors were redesigned to address some of nuclear medicine’s biggest challenges. Shorter photomultiplier tubes combined with lean front-end electronics reduce analog noise and improve performance. And its collimators are optimized to enable high sensitivity, low septal penetration and high resolution even when the detectors are farther from the patient. The result is exceptional NEMA resolution for SPECT in a detector box that is 13 cm slimmer.
In a hybrid system your CT technology is just as important as your SPECT technology. Discovery 670 DR includes the latest in diagnostic CT technology. It’s a 16-slice system with IQ Enhancement technology that enables helical coverage speed equivalent to that of a 50-slice CT scanner at the same table speed1. Our standard feature, Neuro 3D filter (VISR) enables the same image quality by reducing the mA during the acquisition of head images, thereby optimizing the dose required2,3. In addition, ASiRTM may reduce radiation doses4, while Q.AC low dose CTAC enables improved image quality of SPECT studies5. And WideView enables attenuation correction throughout the entire SPECT FOV. Not only does this CT technology add clinical value to SPECT images, it can also function as an additional standalone CT asset that delivers advanced 3D CT imaging applications such as Calcium Scoring, CT Angiography, CTPA and other demanding neurology and ER applications.
Performance in molecular imaging is about generating results you can rely on day in and day out. These improvements to both SPECT and CT technology are the foundation for quantitative results. Results that are made even more valuable with the advanced applications included with the Xeleris workstation.
Exceptional NEMA resolution for SPECT
Up to 50 percent reduction in injected dose or scan time,
with Evolution technology6
Low dose attenuation correction with Q.AC while
preserving SPECT quantitative accuracy7
Standalone, MITA Smart Dose compliant CT capable of performing 95 percent of today’s CT exams
Enabling reduced CT dose for patients of all ages with ASiR4 technology
Reduce total acquisition time for whole-body bone imaging to 16 minutes
Platform compatible with advanced digital solutions designed to connect machines, people and data through a portfolio of healthcare analytics applications